IBDEI3I4 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,560,0)
 ;;=VASCULAR^34^55
 ;;^UTILITY(U,$J,358.4,561,0)
 ;;=OTPT-NEW PATIENT^2^56
 ;;^UTILITY(U,$J,358.4,562,0)
 ;;=OTPT-ESTABLISHED PATIENT^1^56
 ;;^UTILITY(U,$J,358.4,563,0)
 ;;=OTPT-CONSULTATIONS^3^56
 ;;^UTILITY(U,$J,358.4,564,0)
 ;;=INPT-INITIAL OBSERVATION^8^56
 ;;^UTILITY(U,$J,358.4,565,0)
 ;;=INPT-OBSERVATION DISCHARGE^9^56
 ;;^UTILITY(U,$J,358.4,566,0)
 ;;=INPT-BEDSIDE VISIT-INIT^4^56
 ;;^UTILITY(U,$J,358.4,567,0)
 ;;=INPT-BEDSIDE VISITS-DAILY^5^56
 ;;^UTILITY(U,$J,358.4,568,0)
 ;;=INPT-CONSULTATIONS^7^56
 ;;^UTILITY(U,$J,358.4,569,0)
 ;;=ADMIT & DISCHARGE SAME DAY^10^56
 ;;^UTILITY(U,$J,358.4,570,0)
 ;;=DISCHARGE DAY CODES^6^56
 ;;^UTILITY(U,$J,358.4,571,0)
 ;;=NEUROLOGY/SEIZURE/VNS PROGRAMMING^1^57
 ;;^UTILITY(U,$J,358.4,572,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^58
 ;;^UTILITY(U,$J,358.4,573,0)
 ;;=CEREBROVASCULAR DISEASE^2^58
 ;;^UTILITY(U,$J,358.4,574,0)
 ;;=DIZZINESS^3^58
 ;;^UTILITY(U,$J,358.4,575,0)
 ;;=ENCEPHALOPATHY^4^58
 ;;^UTILITY(U,$J,358.4,576,0)
 ;;=HEADACHE^5^58
 ;;^UTILITY(U,$J,358.4,577,0)
 ;;=MOVEMENT DISORDERS^6^58
 ;;^UTILITY(U,$J,358.4,578,0)
 ;;=NEOPLASMS^7^58
 ;;^UTILITY(U,$J,358.4,579,0)
 ;;=NEURODEGENERATIVE DISEASE^8^58
 ;;^UTILITY(U,$J,358.4,580,0)
 ;;=SLEEP DISORDERS^9^58
 ;;^UTILITY(U,$J,358.4,581,0)
 ;;=SPECIAL SCREENING^10^58
 ;;^UTILITY(U,$J,358.4,582,0)
 ;;=OTHER^11^58
 ;;^UTILITY(U,$J,358.4,583,0)
 ;;=CLINICIAN^1^59
 ;;^UTILITY(U,$J,358.4,584,0)
 ;;=PHARMACISTS^1^60
 ;;^UTILITY(U,$J,358.4,585,0)
 ;;=PHYSICAL THERAPISTS^2^60
 ;;^UTILITY(U,$J,358.4,586,0)
 ;;=RADIOLOGIST^4^60
 ;;^UTILITY(U,$J,358.4,587,0)
 ;;=PSYCHOLOGIST^3^60
 ;;^UTILITY(U,$J,358.4,588,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^61
 ;;^UTILITY(U,$J,358.4,589,0)
 ;;=CEREBROVASCULAR DISEASE^2^61
 ;;^UTILITY(U,$J,358.4,590,0)
 ;;=DIZZINESS^3^61
 ;;^UTILITY(U,$J,358.4,591,0)
 ;;=ENCEPHALOPATHY^4^61
 ;;^UTILITY(U,$J,358.4,592,0)
 ;;=HEADACHE^5^61
 ;;^UTILITY(U,$J,358.4,593,0)
 ;;=MOVEMENT DISORDERS^6^61
 ;;^UTILITY(U,$J,358.4,594,0)
 ;;=NEOPLASMS^7^61
 ;;^UTILITY(U,$J,358.4,595,0)
 ;;=NEURODEGENERATIVE DISEASE^8^61
 ;;^UTILITY(U,$J,358.4,596,0)
 ;;=SLEEP DISORDERS^9^61
 ;;^UTILITY(U,$J,358.4,597,0)
 ;;=SPECIAL SCREENING^10^61
 ;;^UTILITY(U,$J,358.4,598,0)
 ;;=OTHER^11^61
 ;;^UTILITY(U,$J,358.4,599,0)
 ;;=EEG LTM^1^62
 ;;^UTILITY(U,$J,358.4,600,0)
 ;;=EEG PROCEDURAL^3^62
 ;;^UTILITY(U,$J,358.4,601,0)
 ;;=EEG ROUTINE^2^62
 ;;^UTILITY(U,$J,358.4,602,0)
 ;;=INTRAOPERATIVE EVOKED POTENTIALS^4^62
 ;;^UTILITY(U,$J,358.4,603,0)
 ;;=NEUROLOGY/SEIZURE/VNS PROGRAMMING^5^62
 ;;^UTILITY(U,$J,358.4,604,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^63
 ;;^UTILITY(U,$J,358.4,605,0)
 ;;=CEREBROVASCULAR DISEASE^2^63
 ;;^UTILITY(U,$J,358.4,606,0)
 ;;=DIZZINESS^3^63
 ;;^UTILITY(U,$J,358.4,607,0)
 ;;=ENCEPHALOPATHY^4^63
 ;;^UTILITY(U,$J,358.4,608,0)
 ;;=HEADACHE^5^63
 ;;^UTILITY(U,$J,358.4,609,0)
 ;;=MOVEMENT DISORDERS^6^63
 ;;^UTILITY(U,$J,358.4,610,0)
 ;;=NEOPLASMS^7^63
 ;;^UTILITY(U,$J,358.4,611,0)
 ;;=NEURODEGENERATIVE DISEASE^8^63
 ;;^UTILITY(U,$J,358.4,612,0)
 ;;=SLEEP DISORDERS^9^63
 ;;^UTILITY(U,$J,358.4,613,0)
 ;;=SPECIAL SCREENING^10^63
 ;;^UTILITY(U,$J,358.4,614,0)
 ;;=OTHER^11^63
 ;;^UTILITY(U,$J,358.4,615,0)
 ;;=PHYSICIAN TELEPHONE CODES^1^64
 ;;^UTILITY(U,$J,358.4,616,0)
 ;;=NON-PHYSICIAN TELEPHONE CALLS^2^64
 ;;^UTILITY(U,$J,358.4,617,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^65
 ;;^UTILITY(U,$J,358.4,618,0)
 ;;=CEREBROVASCULAR DISEASE^2^65
 ;;^UTILITY(U,$J,358.4,619,0)
 ;;=DIZZINESS^3^65
 ;;^UTILITY(U,$J,358.4,620,0)
 ;;=ENCEPHALOPATHY^4^65
 ;;^UTILITY(U,$J,358.4,621,0)
 ;;=HEADACHE^5^65
 ;;^UTILITY(U,$J,358.4,622,0)
 ;;=MOVEMENT DISORDERS^6^65
